期刊文献+

沉默Runt相关转录因子3对骨肉瘤细胞恶性程度的影响 被引量:3

Effect of silencing Runt-related transcription factor 3 on malignancy of osteosarcoma cells
下载PDF
导出
摘要 目的探讨沉默Runt相关转录因子3(RUNX3)对骨肉瘤细胞增殖能力及血管新生能力的影响。方法培养骨肉瘤HEK293细胞株并将其分为NC组和RUNX3组,分别转染阴性对照小干扰RNA(siRNA)和RUNX3-siRNA。于转染siRNA后6、12、24、48 h采用MTS试剂盒测定细胞增殖活力;转染siRNA后24、48 h采用荧光定量PCR试剂盒测定细胞中增殖分子β-链蛋白、细胞周期蛋白D1(Cyclin D1)、增殖细胞核抗原(PCNA)的mRNA表达量,采用ELISA试剂盒测定细胞培养基中血管内皮生长因子(VEGF)、成纤维细胞生长因子(b FGF)、促血管生成素-2(Ang-2)的含量。结果转染siRNA后6、12、24、48 h RUNX3组的细胞增殖活力值均高于NC组(0.78±0.11vs.0.57±0.09,0.99±0.14 vs.0.73±0.10,1.31±0.18 vs.0.81±0.12,1.72±0.26 vs.0.98±0.14,P均<0.05);转染siRNA后24、48 h RUNX3组细胞中β-链蛋白、Cyclin D1、PCNA的mRNA表达量以及细胞培养基中VEGF、b FGF、Ang-2的含量均高于NC组(P均<0.05)。结论沉默RUNX3能够增强骨肉瘤细胞的增殖能力及血管新生能力。 Objective To investigate the effect of silencing Runt-related transcription factor 3 (RUNX3) on the proliferation and angiogenesis of osteosarcoma cells. Methods Osteosarcoma cell line HEK293 was divided into the NC group (transfected with negative control-siRNA) and RUNX3 group (trans-fected with RUNX3-siRNA). At 6h, 12 h, 24 h and 48 h after transfection with siRNA, cell proliferation was determined by MTS kit. At 24 h and 48 h after transfection with siRNA, the expression levels of p-chain pro-tein, CyclinD1 and proliferating cell nu clear antigen (PCNA) mRNA were measured by fluorescent quantita-tive PCR kit. The content of vascular endothelial growth factor ( VEGF) , promote angiogenin-2 (Ang-2 ) and fibroblast growth factor (bFGF) in the culture medium was quantitatively determined by enzyme-linked immu-nosorbent assay kit. Results At 6 h , 12 h , 24 h and 48 h after transfection with siRNA, the activity of cell proliferation in the RUNX3 group was significantly higher than that in the NC group (0. 78 ±0. 11 0. 57 ±0.09, 0.99 ±0. 14 vs .0.73 ±0. 10,1.31 ±0 .18 vs.0 .81 ± 0.12,1.72 ± 0.26vs. 0.98 ± 0.14 ,all P〈0.05). At 24 h and 48 h after transfection with siRNA, the expression levels of p-chain protein, CyclinDl and PCNA mRNA in cells and VEGF, Ang-2 and bFGF in the cultured medium in the RUNX3 group were signifi-cantly higher compared with those in the NC group (all P 〈 0. 05 ). Conclusion Silencing RUNX3 can en-hance the proliferation and angiogenesis of osteosarcoma cells.
出处 《新医学》 2017年第5期313-316,共4页 Journal of New Medicine
基金 广东省医学科学基金(A2015115)
关键词 骨肉瘤 Rimt相关转录因子3 增殖 血管新生 Osteosarcoma Runt-related transcription factor 3 Proliferation Angiogenesis
  • 相关文献

参考文献4

二级参考文献53

  • 1赵晖,顾晓萌,丛波,李希波.恶性食管间质瘤的血管生成拟态研究[J].中华消化杂志,2006,26(6):405-407. 被引量:5
  • 2刘吉兵,李敏,原晓红,高彦.骨肉瘤组织中VEGF和BMP-2表达及微血管密度与转移关系的研究[J].中华肿瘤防治杂志,2007,14(10):776-778. 被引量:8
  • 3刘彤华.诊断病理学[M].2版.北京:人民卫生出版社,2006:40-70.
  • 4TEFFERI A, THIELE J, VARDIMAN J W. The 2008 World Health Organization classification system for my- eloproliferative neoplasms [ J ] . Cancer, 2009, 115 (17) : 3842-3847.
  • 5FINAZZI G, BARBUI T. How I treat patients with pol- ycythemia vera[J]. Blood, 2007, 109 (12) : 5104- 5111.
  • 6VERSTOVSEK S, TEFFERI A. Myeloproliferative Neo- plasms: Biology and Therapy[ M]. New York City: Hu- mana press, 2010: 97-115.
  • 7TEFFERI A, THIELE J, ORAZI A, et al. Proposals and rationale for revision of the World Health Organiza- tion diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recom- mendations from an ad hoc international expert panel [J]. Blood, 2007, 110 (15): 41092-41097.
  • 8CAROBBIO A, FINAZZI G, ANTONIOLI E, et al. Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European Leukemia Net criteria[J]. Blood, 2010, 116 (7): 1051-1055.
  • 9BARBUI T, TEFFERI A. P Myeloproliferative Neo- plasms: Critical Concepts and Management[ M]. Char- lotte, North Carolina: Baker & Taylor Books, 2012: 119-129.
  • 10FINAZZI G, BARBUI T. Evidence and expertise in the management of polycythemia vera and essential thrombo- cythemia[J]. Leukemia, 2008, 22 (8): 1494-1502.

共引文献13

同被引文献32

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部